Topiramate Capsule, Coated Pellets
Product Images NDC 65841-652

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 65841-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eba681d9 6520 4797 B4c5 Bde4e86dbc20 04

Eba681d9 6520 4797 B4c5 Bde4e86dbc20 04
This is a description of Topiramate Capsules, USP with a concentration of 15mg in each capsule. The package includes 60 capsules and the usual dosage is available in the package insert. The drug should be stored at a temperature between 20°-25°C and kept away from moisture. It needs to be dispensed in a container that blocks light. The drug must be kept out of reach of children. Cadia Healthcare Ltd in Ahmedabad, India manufactures this drug.*
FDA Label Image

Eba681d9 6520 4797 B4c5 Bde4e86dbc20 05

Eba681d9 6520 4797 B4c5 Bde4e86dbc20 05
Topiramate capsules with NDC code 65841 manufactured by Cadila Healthcare Ltd. should be stored at a temperature of 20℃ to 25℃ to protect from moisture. The medication guide should be dispensed to each patient, and it should be kept away from children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.